We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Rapid Diagnostic Platform Delivers Up To 30 Results from Single Drop of Body Fluid within 15 Minutes

By HospiMedica International staff writers
Posted on 18 Jan 2023
Print article
ALiA platform delivers multiple results with minimal drop of sample in 15 minutes at POC (Photo courtesy of ALiA BioTech) Crop Article Image
ALiA platform delivers multiple results with minimal drop of sample in 15 minutes at POC (Photo courtesy of ALiA BioTech) Crop Article Image

Thanks to the COVID-19 pandemic, the point-of-care testing (POCT) market is expected to double in size as compared to the pre-pandemic levels. Multiplexing remains the key technology differentiator in this growing field. By increasing the number of simultaneous assays, it becomes possible to identify the right biomarker, and consequently lower the cost and time needed to control a potential outbreak. Now, a next-generation rapid diagnostic platform that is capable of conducting multiplex testing in a single biochip within 15 minutes could become a game changer in the POCT market.

ALiA BioTech’s (Hong Kong) Lab-on-Chip platform is a patented POCT that is capable of delivering up to 30 results from a single drop of body fluid, including blood, serum, swab, or urine. ALiA has completed the R&D of its proprietary microfluidic and microarray technologies, and now aims to scale up the manufacturing of multiplex products for different disease panels. ALiA analyzer and its biochip panels for respiratory infection and tropical fever have been granted the CE marking, with the accredited ISO 13485 medical device quality management system. The company is in the process of securing regulatory approval in other regions, including the U.S., mainland China and Southeast Asia, and will enter into global strategic partnerships for developing biochips for various disease panels.

“A single test on our platform gives the fast track and accurate answer,” said Kelvin Chiu, CEO of ALiA BioTech. “Over the next five to 10 years, we shall develop more multiplex diseases panels and complete clinical trials and regulatory approval processes so that we can introduce more real-time rapid diagnostic panels that are critical to rescuing lives.”

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Computerized Spirometer
DatospirAira

Print article

Channels

Critical Care

view channel
Image: The study assessed the impact of revascularization strategies on patients suffering from chronic limb-threatening ischemia (Photo courtesy of 123RF)

Revascularization Improves Life Quality in Chronic Limb-Threatening Ischemia, Finds Study

Researchers have undertaken a detailed study to evaluate the effects of revascularization strategies on the health-related quality of life (HRQoL) of patients with chronic limb-threatening ischemia.... Read more

Surgical Techniques

view channel
Image: The first intravascular imaging technology has been specifically designed for the brain (Photo courtesy of 123RF)

Miniaturized Snake-Like Probe Images Cerebral Arteries From Within

Endovascular interventions are being increasingly favored for treating strokes and cerebral artery diseases, but rely heavily on angiographical imaging that often struggles with limited contrast and spatial... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more